home > news > detailed info

Nelipak Healthcare Packaging to establish new U.S. flexible packaging facility

Nelipak Healthcare Packaging

New North Carolina site will expand Nelipak’s capabilities from Europe to the Americas

Cranston, RI – December 16, 2022 – Nelipak Corporation (“Nelipak”), a leading global manufacturer of rigid and flexible packaging solutions for medical device, diagnostic, pharmaceutical drug delivery, and other demanding applications, announced that it will establish a new flexible packaging production site in Winston-Salem, North Carolina.

Nelipak currently supplies its industry leading range of healthcare flexible packaging products to customers worldwide from three production sites located in Europe. The addition of a new flagship production site in the U.S. will replicate Nelipak’s existing capabilities to support growing demand in the Americas region. Nelipak’s healthcare flexible packaging product line includes custom-designed roll-stock, die cut lids and sheets, pouches and bags. These products incorporate a range of material substrates (films, Tyvek®, papers, foil-laminates), as well as Nelipak’s range of heat-seal coating technologies Nelipak CR27 and Nelipak SBP2000.

“We are excited to announce our first flexible packaging site in the Americas region,” said Pat Chambliss, CEO of Nelipak. “This site will allow us to provide the same high-quality healthcare flexible packaging products we currently offer to customers worldwide from a new world-class facility with new state-of-the art equipment. Important factors in our site selection include an attractive geographic location within North Carolina’s growing life science cluster, an available new building, a regional emphasis on training and education, a skilled local workforce, and an overall favorable business climate for healthcare-related manufacturing. We appreciate the enthusiasm and support for this project in the local community and look forward to a long-term partnership.”

The new site is a 110,000 square-foot, new construction Class-A industrial building which will be built out to Nelipak’s specifications for healthcare packaging production including ISO-7 clean room space and shall hold ISO 13485 certification. Nelipak expects the project to include approximately $20 million of capital investment and create approximately 80 new jobs over the next five years. The site is expected to open in late 2023.

This initiative is supported by the North Carolina One NC fund as well as the Economic Development Partnership of North Carolina who were key partners in the project that included the North Carolina General Assembly, North Carolina Community College System, Forsyth County, City of Winston-Salem and Greater Winston-Salem, Inc.
phone +353 91 757 152
email Unit 6D, Mervue Business Park, Galway, Ireland
Print this page
Send to a friend
News and Press Releases

LEO Pharma and ICON enter a strategic partnership to propel clinical trial execution within medical dermatology

BALLERUP, DENMARK and DUBLIN, IRELAND — 10 March, 2023 — LEO Pharma, a global leader in medical dermatology, and ICON plc (NASDAQ: ICLR) today announced a strategic partnership that will enable LEO Pharma to scale clinical trial execution that is patient-centric and cost effective, and which will support the company’s overall ambition of building one of the most effective and efficient clinical portfolio execution organisations in the industry.
More info >>

White Papers

Antibody Internalization: Advanced Flow Cytometry and Live-Cell Analysis Give Rich Insights During Antibody Profiling

Sartorius Group

The natural characteristics of antibodies, such as high binding affinity, specificity to a wide variety of targets, and good stability, make them ideal therapeutic candidates for many diseases. Monoclonal antibodies (mAbs), in particular, deliver promising therapeutic results in several different disease areas, such as autoimmunity, oncology, and chronic inflammation. Researchers’ abilities to improve the breadth of antibodies have been aided by innovative technologies for antibody discovery, for instance, through humanization of mouse antibodies and phage display. However, advanced antibody design techniques create the need for new screening methods so that lead candidates can be quickly and effectively identified as early in the development process as possible.
More info >>

Industry Events

The Pharmaceutical Manufacturing and Packaging Congress 2023 (PHARMAP 2023)

12-13 June 2023, Hilton Geneva Hotel & Conference Centre, Geneva, Switzerland

The Pharmaceutical Manufacturing and Packaging Congress 2023 (PHARMAP 2023) gathers top-level management from pharmaceutical companies of manufacturing, primary and secondary packaging, purchasing, and supply chain and procurement sectors, CMOs and CDMOs leaders, heads from government and institution on 12-13, June, 2023 in Geneva, Switzerland.
More info >>

©2000-2011 Samedan Ltd.
Add to favourites

Print this page

Send to a friend
Privacy statement